BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 28444845)

  • 1. Predictors of complication following lower extremity amputation in diabetic end-stage renal disease.
    Park YH; Song JH; Choi GW; Kim HJ
    Nephrology (Carlton); 2018 Jun; 23(6):518-522. PubMed ID: 28444845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes.
    Mohammedi K; Potier L; Belhatem N; Matallah N; Hadjadj S; Roussel R; Marre M; Velho G
    Cardiovasc Diabetol; 2016 Jan; 15():5. PubMed ID: 26743116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Meta-analysis of Long-term Mortality and Associated Risk Factors following Lower Extremity Amputation.
    Stern JR; Wong CK; Yerovinkina M; Spindler SJ; See AS; Panjaki S; Loven SL; D'Andrea RF; Nowygrod R
    Ann Vasc Surg; 2017 Jul; 42():322-327. PubMed ID: 28389295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for unplanned readmission and stump complications after major lower extremity amputation.
    Phair J; DeCarlo C; Scher L; Koleilat I; Shariff S; Lipsitz EC; Garg K
    J Vasc Surg; 2018 Mar; 67(3):848-856. PubMed ID: 29079006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting perioperative mortality and wound-related complications following major lower extremity amputations.
    Stone PA; Flaherty SK; Aburahma AF; Hass SM; Jackson JM; Hayes JD; Hofeldt MJ; Hager CS; Elmore MS
    Ann Vasc Surg; 2006 Mar; 20(2):209-16. PubMed ID: 16586027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the risk of non-traumatic lower extremity amputation between haemodialysis and peritoneal dialysis patients with end-stage renal disease.
    Wang IK; Hsu CH; Tsai CH; Chang SS; Lin CL; Yen TH; Lin SY; Lin CC; Liu JH; Chang CT; Sung FC
    Nephrology (Carlton); 2018 Jan; 23(1):86-92. PubMed ID: 27723258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and indications for readmission after lower extremity amputation in the American College of Surgeons National Surgical Quality Improvement Program.
    Curran T; Zhang JQ; Lo RC; Fokkema M; McCallum JC; Buck DB; Darling J; Schermerhorn ML
    J Vasc Surg; 2014 Nov; 60(5):1315-1324. PubMed ID: 24985536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Lower Extremity Minor Amputation Conversion to Major Amputation.
    Rolle NP; Kawaji Q; Morton C; Rosenberg KM; Kalsi R; Blitzer DN; Nagarsheth K
    Ann Vasc Surg; 2024 Jul; 104():166-173. PubMed ID: 38387800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower extremity amputations: factors associated with mortality or contralateral amputation.
    Shah SK; Bena JF; Allemang MT; Kelso R; Clair DG; Vargas L; Kashyap VS
    Vasc Endovascular Surg; 2013 Nov; 47(8):608-13. PubMed ID: 24005190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Through-knee amputation is a feasible alternative to above-knee amputation.
    Lim S; Javorski MJ; Halandras PM; Aulivola B; Crisostomo PR
    J Vasc Surg; 2018 Jul; 68(1):197-203. PubMed ID: 29567029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Patients Undergoing Major Lower Extremity Amputation in the Vascular Quality Initiative.
    Gabel J; Jabo B; Patel S; Kiang S; Bianchi C; Chiriano J; Teruya T; Abou-Zamzam AM;
    Ann Vasc Surg; 2018 Jan; 46():75-82. PubMed ID: 28887250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for lower extremity amputation among patients with diabetes in Singapore.
    Yang Y; Østbye T; Tan SB; Abdul Salam ZH; Ong BC; Yang KS
    J Diabetes Complications; 2011; 25(6):382-6. PubMed ID: 21983153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of operative mortality following major lower extremity amputations using the National Surgical Quality Improvement Program public use data.
    Karam J; Shepard A; Rubinfeld I
    J Vasc Surg; 2013 Nov; 58(5):1276-82. PubMed ID: 23830311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frailty Index associated with postoperative complications and mortality after lower extremity amputation in a national veteran cohort.
    Tse W; Dittman JM; Lavingia K; Wolfe L; Amendola MF
    J Vasc Surg; 2021 Sep; 74(3):963-971. PubMed ID: 33684477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the incidence of and risk factors for reamputation among patients who underwent foot amputation.
    Kono Y; Muder RR
    Ann Vasc Surg; 2012 Nov; 26(8):1120-6. PubMed ID: 22840342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term contemporary outcomes for staged versus primary lower limb amputation in diabetic foot disease.
    Cheun TJ; Jayakumar L; Sideman MJ; Ferrer L; Mitromaras C; Miserlis D; Davies MG
    J Vasc Surg; 2020 Aug; 72(2):658-666.e2. PubMed ID: 31901363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients With Diabetic Foot Disease Fear Major Lower-Extremity Amputation More Than Death.
    Wukich DK; Raspovic KM; Suder NC
    Foot Ankle Spec; 2018 Feb; 11(1):17-21. PubMed ID: 28817962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative frailty is predictive of complications after major lower extremity amputation.
    Fang ZB; Hu FY; Arya S; Gillespie TW; Rajani RR
    J Vasc Surg; 2017 Mar; 65(3):804-811. PubMed ID: 28236922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood transfusion and its effect on the clinical outcomes of patients undergoing major lower extremity amputation.
    D'Ayala M; Huzar T; Briggs W; Fahoum B; Wong S; Wise L; Tortolani A
    Ann Vasc Surg; 2010 May; 24(4):468-73. PubMed ID: 19900785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining successful mobility after lower extremity amputation for complications of peripheral vascular disease and diabetes.
    Norvell DC; Turner AP; Williams RM; Hakimi KN; Czerniecki JM
    J Vasc Surg; 2011 Aug; 54(2):412-9. PubMed ID: 21531528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.